在第一线设置中的扩展阶段小细胞肺癌的基于炎症的预后:高级肺炎指数和其他人
Erdoğan Selçuk Şeber1, Ömer Faruk Elçiçek1, Eyyüp Çavdar2
1Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdağ, Turkey.
Asia-Pacific journal of clinical oncology
|June 18, 2025
概括
晚期肺炎指数 (ALI) 是接受化疗的广发小细胞肺癌 (ES-SCLC) 患者的强有力的预后标志物. 这种易于获取的标志物有助于成本效益高的后续和治疗决策.
科学领域:
- 在瘤学瘤学.
- 医学诊断 医学诊断 医学诊断
- 炎症研究 炎症研究
背景情况:
- 扩散性小细胞肺癌 (ES-SCLC) 是一个重大的临床挑战.
- 预后标记对于ES-SCLC治疗决策的指导至关重要.
- 炎症指数越来越多地被认为是它们在癌症中的潜在预后价值.
研究的目的:
- 为了评估炎症指数的预后意义,包括晚期肺炎指数 (ALI),在ES-SCLC患者接受一线白金-乙托化疗.
- 确定可靠的标记物来预测ES-SCLC的生存结果.
主要方法:
- 分析了一组167名ES-SCLC患者的队列,这些患者接受了第一线白金-埃托化疗.
- 收集了人口统计学,临床病理学和治疗前的血液参数.
- 进行了单变量和多变量分析,以评估各种标志物的预后价值.
主要成果:
- 晚期肺炎指数 (ALI) 被确定为ES-SCLC患者整体生存期 (OS) 的独立预后因素 (HR = 0.68,p = 0.016).
- 其他炎症指数,如C反应蛋白-白蛋白-淋巴细胞指数 (CALLY) 和全身免疫炎症指数 (SII),以及ECOG性能状态,在单变量分析中也显示出预后价值.
- 根据CALLY,SII,ALI和ECOG的性能状态,中位数的OS显著不同.
结论:
- 晚期肺炎指数 (ALI) 是使用化疗治疗的ES-SCLC患者的强有力的预后标志物.
- CALLY,SII和ECOG绩效状态也是有价值的预后指标.
- 这些易于计算的标记可以帮助临床医生实时评估和决策,以实现成本有效的患者管理.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
545
相关概念视频
01:22Burn Injuries
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...